BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Amkor Technology
AMKR
$14.7B
| $68.6K | ﹤0.01% |
5,570
-95,979
| -95% | -$991K |
|
2777
Gossamer Bio
GOSS
$75.4M
| $68.6K | ﹤0.01% |
5,274
-16,771
| -76% | -$211K |
|
2778
Silicon Motion
SIMO
$9.12B
| $68.3K | ﹤0.01% |
+1,400
| New | +$62K |
|
2779
Oxford Industries
OXM
$543M
| $67.6K | ﹤0.01% |
1,537
-5,522
| -78% | -$230K |
|
2780
CALL
Chord Energy
CHRD
$7.51B
| $67.5K | ﹤0.01% |
+900
| New | +$582 |
|
2781
Scholastic
SCHL
$781M
| $67.5K | ﹤0.01% |
2,253
-10,139
| -82% | -$292K |
|
|
VSTO
2782
DELISTED
Vista Outdoor Inc.
VSTO
| $67.3K | ﹤0.01% |
4,660
-343,438
| -99% | -$3.44M |
|
|
RWT
2783
Redwood Trust
RWT
$604M
| $67.3K | ﹤0.01% |
9,612
-37,603
| -80% | -$185K |
|
|
RPT
2784
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $67.2K | ﹤0.01% |
9,661
-24,325
| -72% | -$155K |
|
2785
National Bank Holdings
NBHC
$1.94B
| $67K | ﹤0.01% |
2,481
-10,154
| -80% | -$259K |
|
|
GES
2786
DELISTED
Guess Inc
GES
| $66.9K | ﹤0.01% |
6,921
-95,883
| -93% | -$843K |
|
2787
AMERISAFE
AMSF
$513M
| $66.7K | ﹤0.01% |
1,091
-6,511
| -86% | -$405K |
|
2788
TriMas Corp
TRS
$1.4B
| $66.4K | ﹤0.01% |
2,773
-12,096
| -81% | -$278K |
|
|
BPMP
2789
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $66.1K | ﹤0.01% |
5,762
-323
| -5% | -$3.69K |
|
2790
Park National Corp
PRK
$3.75B
| $66K | ﹤0.01% |
938
-3,500
| -79% | -$256K |
|
|
KNOW
2791
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
| $65.8K | ﹤0.01% |
2,000
| – | – |
|
2792
Stride
LRN
$3.46B
| $65.6K | ﹤0.01% |
2,407
-10,720
| -82% | -$258K |
|
2793
Kura Oncology
KURA
$964M
| $65.2K | ﹤0.01% |
3,998
-10,194
| -72% | -$147K |
|
|
BMCH
2794
DELISTED
BMC Stock Holdings, Inc
BMCH
| $65.2K | ﹤0.01% |
2,592
-22,587
| -90% | -$500K |
|
|
FLXN
2795
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $65K | ﹤0.01% |
4,941
-14,671
| -75% | -$152K |
|
|
RRD
2796
DELISTED
RR Donnelley & Sons Co.
RRD
| $64.7K | ﹤0.01% |
54,373
+23,348
| +75% | +$28.4K |
|
2797
Fomento Económico Mexicano
FMX
$40.3B
| $64.4K | ﹤0.01% |
1,039
-21,260
| -95% | -$1.35M |
|
|
BRKL
2798
DELISTED
Brookline Bancorp
BRKL
| $64.3K | ﹤0.01% |
6,378
-26,484
| -81% | -$264K |
|
2799
Krystal Biotech
KRYS
$9.83B
| $64.1K | ﹤0.01% |
1,548
-3,929
| -72% | -$189K |
|
|
CHAP
2800
DELISTED
Chaparral Energy, Inc.
CHAP
| $64.1K | ﹤0.01% |
98,906
+89,343
| +934% | +$47K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.